CD47 and Thrombocytopenia: For example, when anti-CD47 antibodies are used to inhibit the interaction between CD47 on CTCs and SIRPα on neutrophils, thereby enhancing neutrophil phagocytosis of CTCs, free anti-CD47 antibodies lack specificity and may cause limitations such as red blood cell toxicity and thrombocytopenia [17].